Hemostatic Factors and Subclinical Brain Infarction in a Community-Based Sample: The ARIC Study

Cerebrovascular Diseases

Volumn 28, Issue 6, 2009, Pages 589-594

  Gottesman, R F ^a,h   Cummiskey, C ^b   Chambless, L ^c   Wu, K K ^g   Aleksic, N ^d   Folsom, A R ^e   Sharrett, A R ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c IL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^h NONE   (United States)

Author keywords

Cerebral infarction; Epidemiology; Hemostatic disorders; Lacunar infarction; Magnetic resonance imaging

Indexed keywords

D DIMER; PLASMINOGEN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BRAIN INFARCTION; COMMUNITY SAMPLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRAIN INFARCTION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMINOGEN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; VON WILLEBRAND FACTOR;

EID: 70350057028     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247603     Document Type: Article

References (25)

1. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK: Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999; 100: 736-742. (Pubitemid 29383644)
2. Folsom AR, Wu KK, Shahar E, Davis CE: Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb 1993; 13: 1829-1836.
3. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK: Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Circulation 1995; 91: 284-290.
4. Knuiman MW, Folsom AR, Chambless LE, Liao D, Wu KK: Association of hemostatic variables with MRI-detected cerebral abnormalities: The Atherosclerosis Risk in Communities Study. Neuroepidemiology 2001; 20: 96-104.
5. Fisher CM: Lacunes: small, deep cerebral infarcts. Neurology 1965; 15: 774-784.
6. Fisher CM: Lacunar strokes and infarcts: a review. Neurology 1982; 32: 871-876.
7. Knopman DS, Mosley TH, Catellier DJ, Sharrett AR: Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 2005; 65: 876-881.
8. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3,660 elderly people. Arch Neurol 1998; 55: 1217-1225.
9. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, Carr J, Furberg CD: Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly. The Cardiovascular Health Study. Stroke 2002; 33: 2376-2382.
10. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK: Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001; 21: 611-617. (Pubitemid 32323396)
11. Wu KK, Aleksic N, Ballantyne CM, Ahn C, Juneja H, Boerwinkle E: Interaction between soluble thrombomodulin and intracellular adhesion molecule-1 in predicting risk of coronary heart disease. Circulation 2003; 107: 1729-1732.
12. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK: C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2002; 144: 233-238. (Pubitemid 34879645)
13. Ghaddar HB, Cortes J, Salomaa V, Kark JD, Davis CE, Folsom AR, Heiss G, Stinson V, Wu KK: Correlation of specific platelet activation markers with carotid arterial wall thickness. Thromb Haemost 1995; 74: 943-948.
14. Nguyen ND, Ghaddar H, Stinson V, Chambless LE, Wu KK: ARIC Hemostasis Study - IV. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk in Communities (ARIC). Thromb Haemost 1995; 73: 256-260.
15. Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M: Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. Stroke 2008; 39: 2268-2273.
16. Chambless LE, McMahon R, Wu K, Folsom AR, Finch A, Shen YL: Short-term intraindividual variability in hemostasis factors: the ARIC Study. Ann Epidemiol 1992; 2: 723-733.
17. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK: Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999; 353: 1729-1734.
18. Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR: Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) Study cohort. Vasc Med 2007; 12: 267-273.
19. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH: Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-1687.
20. Kario K, Matsuo T, Kobayashi H, HoshiDe S, Shimada K: Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol 2001; 37: 871-877.
21. Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB: Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 1996; 27: 1066-1071.
22. Carter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ: Predictive variables for mortality after acute ischemic stroke. Stroke 2007; 38: 1873-1880.
23. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Schlomo Y, Lowe G: Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005; 112: 3080-3087.
24. Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-3325.
25. Lip GYH, Watson T, Shantsila E: Anticoagulation for stroke prevention in atrial fibrillation: is gender important? Eur Heart J 2006; 27: 1893-1894.